About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
Our research group is accredited by the Agency for Management of University and Research Grants (AGAUR) in Catalonia, and focuses on two main areas of interest which are related to Solid Organ Transplantation and especially Kidney, and in clinical Nephrology. We tackle these areas from an innovative perspective, both basic-experimental and mechanistic, always with a translational goal. On the one hand, we investigate, develop, and use novel diagnostic and therapeutic technologies to decipher and target main molecular and immune mechanisms of transplant rejection as well as the immune susceptibility to opportunistic infections and malignancies. Also, a main task force of the group is devoted to better understand the main mechanisms involved in certain autoimmune glomerular diseases and idiopathic nephrotic syndrome as well as in diabetic kidney disease, having a specific interest in the role of the renin-angiotensin system. Our ultimate goal is to improve the management and care of patients suffering from kidney diseases as well as their quality of life, reducing associated morbidity and mortality.
PMID: 35629041 Journal: Journal of Clinical Medicine Year: 2022 Reference: J Clin Med. 2022 May 21;11(10). pii: jcm11102915. doi: 10.3390/jcm11102915. Impact factor: 4.242 Publication type: Paper in international publication Authors: Blasco, Miquel, Quintana, Luis F, Shabaka, Amir, Rabasco, Cristina, Draibe, Juliana, Merino, Ana, Melero, Maria Rosa, Alonso, Fabiola, Buxeda, Anna, Batalha, Paula et al. DOI: 10.3390/jcm11102915
PMID: 33533909 Journal: NEPHROLOGY DIALYSIS TRANSPLANTATION Year: 2022 Reference: Nephrol Dial Transplant. 2022 Mar 25;37(4):697-704. doi: 10.1093/ndt/gfab020. Impact factor: 5.992 Publication type: Paper in international publication Authors: Rodriguez, Eva, Latzke, Belen, Sierra, Milagros, Romera, Ana Maria, Siedel, Diego, Agraz, Irene, Soler, Maria Jose, Garcia-Carro, Clara, Draibe, Juliana, de la Prada, Francisco Jose et al. DOI: 10.1093/ndt/gfab020
PMID: 35583251 Journal: NEPHROLOGY DIALYSIS TRANSPLANTATION Year: 2022 Reference: Nephrol Dial Transplant. 2022 May 18. pii: 6588052. doi: 10.1093/ndt/gfac185. Impact factor: 5.992 Publication type: Paper in international publication Authors: Segarra, Alfons, Garcia, Alicia, Abo, Anabel, Gonzalez, Jorge, Jatem, Elias, Roig, Jordi, Valtierra, Naiara, Ostos, Elena, Santacana, Maria et al. DOI: 10.1093/ndt/gfac185
PMID: 35551070 Journal: Clinical Journal of the American Society of Nephro Year: 2022 Reference: Clin J Am Soc Nephrol. 2022 Jun;17(6):872-876. doi: 10.2215/CJN.01770222. Epub 2022 May 12. Impact factor: 8.237 Publication type: Letter whit IF Authors: Puerta Carretero, Marta, Jaldo Rodriguez, Maria Teresa, Carnerero Di Riso, Manuel Antonio, Martinez, Shaira, Gonzalez, Carmen Calderon, Cervienka, Michal, Macias Carmona, Nicolas, Arroyo, David, Perez Del Valle, Katia M, de Arriba, Gabriel et al. DOI: 10.2215/CJN.01770222
PMID: 34069888 Journal: Journal of Clinical Medicine Year: 2021 Reference: J Clin Med. 2021 May 18;10(10). pii: jcm10102174. doi: 10.3390/jcm10102174. Impact factor: 4.242 Publication type: Paper in international publication Authors: Agraz, Irene, Moreso, Francesc, Soler, Maria Jose, Seron, Daniel, Lopez-Hellin, Joan, Villena-Ortiz, Yolanda, Sellares, Joana, Vergara, Ander, Jacobs-Cacha, Conxita, Puig-Gay, Natalia et al. DOI: 10.3390/jcm10102174
PMID: 34072230 Journal: Journal of Clinical Medicine Year: 2021 Reference: J Clin Med. 2021 May 27;10(11). pii: jcm10112364. doi: 10.3390/jcm10112364. Impact factor: 4.242 Publication type: Review in international publication Authors: Delgado, Pilar, Soler, Maria Jose, Pujadas, Francesc, Maisterra, Olga, Jimenez-Balado, Joan, Ariton, Diana Maria et al. DOI: 10.3390/jcm10112364
PMID: 33340043 Journal: NEPHROLOGY DIALYSIS TRANSPLANTATION Year: 2021 Reference: Nephrol Dial Transplant. 2021 Jan 1;36(1):87-94. doi: 10.1093/ndt/gfaa314. Impact factor: 5.992 Publication type: Paper in international publication Authors: Ortiz, Alberto, Cozzolino, Mario, Fliser, Danilo, Fouque, Denis, Goumenos, Dimitrios, Massy, Ziad A, Rosenkranz, Alexander R, Rychlik, Ivan, Soler, Maria Jose, Stevens, Kate et al. DOI: 10.1093/ndt/gfaa314
PMID: 33339673 Journal: NEFROLOGIA Year: 2021 Reference: Nefrologia. 2021 May-Jun;41(3):237-243. doi: 10.1016/j.nefro.2020.09.004. Epub 2020 Dec 16. Impact factor: 2.033 Publication type: Review in national publication Authors: Pascual, Julio, Rodriguez Manas, Leocadio, Perez-Saez, Maria Jose, Gutierrez-Dalmau, Alex, Moreso, Francesc et al. DOI: 10.1016/j.nefro.2020.09.004
The Department of Health of the Generalitat de Catalunya grants subsidies for carrying out validation tests on innovative projects in the field of health that are in the early stages of development.
Hypertension, a key risk factor for heart disease that contributes significantly to cardiovascular mortality and morbidity and damage to vital organs, was the focus of this multi-centre study.
The new findings were presented at the American Society of Nephrology's Kidney Week 2024 meeting in San Diego and simultaneously published in the prestigious journal Nature Medicine.
